Trial · NCT02867878
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | left ventricle ejection fraction (%) | 48 hours | an indipendent corelab will review all images from 48-hour ecocardiography to establish LVEF value (%) |
| Secondary | left ventricle ejection fraction (%) | 24 hours | an indipendent corelab will review all images from 24-hour ecocardiography to establish LVEF value (%) |
| Secondary | left ventricle ejection fraction (%) | 1 month | an indipendent corelab will review all images from 1-month ecocardiography to establish LVEF value (%) |
| Secondary | wall motion score index | 24 hours | an indipendent corelab will review all images from 24-hour ecocardiography to calculate WMSI value (number) |
| Secondary | wall motion score index | 48 hours | an indipendent corelab will review all images from 48-hour ecocardiography to calculate WMSI value (number) |
| Secondary | wall motion score index | 1 month | an indipendent corelab will review all images from 1-month ecocardiography to calculate WMSI value (number) |
| Secondary | acute heart failure | 1 month | it is defined as dyspnea + crackles on auscultation + signs on X-ray of chest congestion |
| Secondary | intravenous diuretics | 1 month | it is defined as the total count of mg of furosemide |
| Secondary | emergency room admission | 1 month | Access to the emergency room for dyspnea/heart failure |
| Secondary | major adverse events | 1 year | cumulative incidence of all-cause death and hospital admission for cardiovascular causes |
| Secondary | hypokinetic arrhythmias | 1 hour | cumulative occurrence of hypokinetic arrhythmias (asystole, atrio-venticular block) in the course of administration of adenosine as shown by electrocardiogram recording |
| Secondary | arterial hypotension | 1 hour | persistent hypotension (arterial blood pressure \<90 mmHg) during administration of adenosine as shown by invasive blood pressure recording |
| Secondary | side effects | 1 hour | Persistent symptoms (nausea, dyspnea, hot flush, etc.) that require premature discontinuation of the administration of adenosine |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02867878/registered